China (Mainland)
Fmoc-NH-PEG2-CH2CH2COOH CAS NO.872679-70-4
- FOB Price: USD: /Kilogram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,MoneyGram,Other
- Available Specifications:
good(1-10)Kilogram
- Product Details
Keywords
- Fmoc-9-Amino-4,7-Dioxanonanoic acid
- high purity Fmoc-9-Amino-4,7-Dioxanonanoic acid
- Fmoc-AEEP-OH≥ 98% (HPLC)
Quick Details
- ProName: Fmoc-NH-PEG2-CH2CH2COOH
- CasNo: 872679-70-4
- Molecular Formula: C22H25NO6
- Appearance: White to nearly white powder
- Application: medical intermediate
- DeliveryTime: available goods in stock
- PackAge: inside: glass bottle Outside: paper d...
- Port: any port in China
- ProductionCapacity: more than 10 Kilogram/Month
- Purity: ≥98%
- Storage: Store at 2-8°C
- Transportation: CIF by air or DAP by courier, FOB,EX w...
- LimitNum: 1 Gram
- Moisture Content: not more than 1.0%
- Impurity: not more than 0.5
- Purity: more than 98.0%
Superiority
Fmoc-NH-PEG2-CH2CH2COOH
CAS:872679-70-4
Molecular Weight:399.44
Molecular Formula:C22H25NO6
Appearance:White to off-white powder
Application:Medical intermediate
Delivery Time:Customized
Package: inside:glass bottle outside: paper drum
Port:Any port in China
Production Capacity:More than 10kg
Purity:≥98%
Storage:Store at 2-8°C
Transportation:CIF by air or DAP by courier, FOB, EX W Etc...
We have produced this product many years and now got scale production .Purity can reach more than 98%.
The Corporation's main product are high purity single molecular PEG series derivatives, hydroxyproline series derivatives, polypeptide long acting drug side chain and its intermediates (including Semaglutide side chain, liraglutide side chain, Degu insulin side chain, long-acting production hormone, etc.), and short peptide drugs modified side chains (semaglutide dipeptide, tetrapeptide).
Our company is working with innovative pharmaceutical companies to build a platform for research and development of polypeptide long-acting drugs, and is committed to building a systematic and diverse long-acting side chain library, establishing molecular blocks of polypeptide long-acting side chains, and providing various development solutions for customers to develop polypeptide long-acting drugs.
We have produced this product many years and now got scale production .Purity can reach more than 98%.
The Corporation's main product are high purity single molecular PEG series derivatives, hydroxyproline series derivatives, polypeptide long acting drug side chain and its intermediates (including Semaglutide side chain, liraglutide side chain, Degu insulin side chain, long-acting production hormone, etc.), and short peptide drugs modified side chains (semaglutide dipeptide, tetrapeptide).
Our company is working with innovative pharmaceutical companies to build a platform for research and development of polypeptide long-acting drugs, and is committed to building a systematic and diverse long-acting side chain library, establishing molecular blocks of polypeptide long-acting side chains, and providing various development solutions for customers to develop polypeptide long-acting drugs.
Chengdu Pukang Biological Technology Co., Ltd. was established in 2008, located in the national Cross-strait science and technology industrial development park -- Chengdu Wenjiang District Strait Science and Technology Park, specializing in the long-term development of chronic disease polypeptide drugs.As a production, sales, research and development as one of the manufacturers.At present, the company has 2400 square meters of RESEARCH and development center, 1000 square meters of production workshop.Plan to build 12000 square meters of production base, according to GMP standard quality system management.In recent years, Pukang pharmaceutical has been audited more than ten times by well-known pharmaceutical enterprises at home and abroad, and has been recognized.
For set production, sales, research and development as one of the manufacturers. At present, the company has 2400 square meters of RESEARCH and development center, 1000 square meters of production workshop. Plan to build 12000 square meters of production base, according to GMP standard quality system management. In recent years, Pukang pharmaceutical has been approved by well-known pharmaceutical enterprises at home and abroad for more than ten times. The main products of the company are high purity single molecule polyethylene glycol derivatives, long-term drug side chains of polypeptides and their intermediates (including cimerlutide side chains, Liraglutide side chains, insulin Degludec side chains, human growth hormone side chains, etc.), short peptide drug modified side chains (dipeptide, tetrapeptide). The company is cooperating with innovation Pharmaceutical company to establish a long-term peptide drug development platform, committed to building a systematic variety of long-term peptide side chain library, establish long-term peptide side chain molecular blocks, and provide customers with a variety of long-term peptide drug development solutions. Companies adhering to the "quality first, technology first" concept, to provide customers around the world with the best products and the best service.
Details
Fmoc-NH-PEG2-CH2CH2COOH
CAS:872679-70-4
Molecular Weight:399.44
Molecular Formula:C22H25NO6
Appearance:White to off-white powder
Application:Medical intermediate
Delivery Time:Customized
Package: inside:glass bottle outside: paper drum
Port:Any port in China
Production Capacity:More than 10kg
Purity:≥98%
Storage:Store at 2-8°C
Transportation:CIF by air or DAP by courier, FOB, EX W Etc...
We have produced this product many years and now got scale production .Purity can reach more than 98%.
The Corporation's main product are high purity single molecular PEG series derivatives, hydroxyproline series derivatives, polypeptide long acting drug side chain and its intermediates (including Semaglutide side chain, liraglutide side chain, Degu insulin side chain, long-acting production hormone, etc.), and short peptide drugs modified side chains (semaglutide dipeptide, tetrapeptide).
Our company is working with innovative pharmaceutical companies to build a platform for research and development of polypeptide long-acting drugs, and is committed to building a systematic and diverse long-acting side chain library, establishing molecular blocks of polypeptide long-acting side chains, and providing various development solutions for customers to develop polypeptide long-acting drugs.
We have produced this product many years and now got scale production .Purity can reach more than 98%.
The Corporation's main product are high purity single molecular PEG series derivatives, hydroxyproline series derivatives, polypeptide long acting drug side chain and its intermediates (including Semaglutide side chain, liraglutide side chain, Degu insulin side chain, long-acting production hormone, etc.), and short peptide drugs modified side chains (semaglutide dipeptide, tetrapeptide).
Our company is working with innovative pharmaceutical companies to build a platform for research and development of polypeptide long-acting drugs, and is committed to building a systematic and diverse long-acting side chain library, establishing molecular blocks of polypeptide long-acting side chains, and providing various development solutions for customers to develop polypeptide long-acting drugs.
Chengdu Pukang Biological Technology Co., Ltd. was established in 2008, located in the national Cross-strait science and technology industrial development park -- Chengdu Wenjiang District Strait Science and Technology Park, specializing in the long-term development of chronic disease polypeptide drugs.As a production, sales, research and development as one of the manufacturers.At present, the company has 2400 square meters of RESEARCH and development center, 1000 square meters of production workshop.Plan to build 12000 square meters of production base, according to GMP standard quality system management.In recent years, Pukang pharmaceutical has been audited more than ten times by well-known pharmaceutical enterprises at home and abroad, and has been recognized.
For set production, sales, research and development as one of the manufacturers. At present, the company has 2400 square meters of RESEARCH and development center, 1000 square meters of production workshop. Plan to build 12000 square meters of production base, according to GMP standard quality system management. In recent years, Pukang pharmaceutical has been approved by well-known pharmaceutical enterprises at home and abroad for more than ten times. The main products of the company are high purity single molecule polyethylene glycol derivatives, long-term drug side chains of polypeptides and their intermediates (including cimerlutide side chains, Liraglutide side chains, insulin Degludec side chains, human growth hormone side chains, etc.), short peptide drug modified side chains (dipeptide, tetrapeptide). The company is cooperating with innovation Pharmaceutical company to establish a long-term peptide drug development platform, committed to building a systematic variety of long-term peptide side chain library, establish long-term peptide side chain molecular blocks, and provide customers with a variety of long-term peptide drug development solutions. Companies adhering to the "quality first, technology first" concept, to provide customers around the world with the best products and the best service.